(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer

Monoclonal antibodies (mAbs) against the epidermal growth factor receptor (EGFR) are used in the treatment of advanced colorectal cancer (mCRC). Approximately 50% of patients benefit despite patient selection for RAS wild type (wt) tumors. Based on the hypothesis that tumor targeting is required for...

Descripción completa

Detalles Bibliográficos
Autores principales: Menke-van der Houven van Oordt, Catharina Willemien, Gootjes, Elske C., Huisman, Marc C., Vugts, Danielle J., Roth, Chantal, Luik, Anne Marije, Mulder, Emma R., Schuit, Robert C., Boellaard, Ronald, Hoekstra, Otto S., van Dongen, Guus AMS, Verheul, Henk M.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745807/
https://www.ncbi.nlm.nih.gov/pubmed/26309164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745807/
https://www.ncbi.nlm.nih.gov/pubmed/26309164

Ejemplares similares